MENINGOCOCCAL VACCINE - DO SOME CHILDREN EXPERIENCE SIDE-EFFECTS
- 22 February 1989
- journal article
- research article
- Vol. 102 (862), 65-67
Abstract
In order to stop an outbreak of group A meningococcal meningitis, 130,000 Auckland children were immunised. During the month following vaccination there were 546 reports of unusual clinical events reported by parents and practitioners, together with 40 specialist paediatric assessments of children presenting with neurological symptoms. In 25 of these latter there was complete agreement between the history as presented by parents in the initial telephone report and the paediatrician''s subsequent summarised history. Of the 546 reports, 217 either had too little detail for an assessment or the symptoms were clearly attributable to other causes. Of the remaining reports, there were 152 cases of fever with or without other symptoms; 85 were of rash and local reactions within 24h of vaccination; 63 reports were of headache, stiff neck and myalgia within 48h of vaccination. There were 92 reports of apparent peripheral nerve involvement, including 80 reports of unexplained weakness and 57 reports of paraesthesia or dysaesthesia. Both motor and sensory symptoms occurred in some children; none were permanent. The effects of adverse publicity during the campaign on the genesis of some symptoms is acknowledged, but the possibility that short term neurological symptoms occur after vaccination seems likely and has not been previously reported.This publication has 6 references indexed in Scilit:
- Pertussis immunisation and serious acute neurological illness in children.BMJ, 1981
- Serum Antibodies to Capsular Polysaccharide Vaccine of Group A Neisseria meningitidis Followed for Three Years in Infants and ChildrenThe Journal of Infectious Diseases, 1980
- Kinetics of Antibody Production to Group A and Group C Meningococcal Polysaccharide Vaccines Administered during the First Six Years of Life: Prospects for Routine Immunization of Infants and ChildrenThe Journal of Infectious Diseases, 1979
- Toxicity of pertussis vaccine: frequency and probability of reactionsJournal of Epidemiology and Community Health, 1979
- Meningococcus group A vaccine in children three months to five years of ageThe Journal of Pediatrics, 1978
- Clinical Efficacy of Meningococcus Group A Capsular Polysaccharide Vaccine in Children Three Months to Five Years of AgeNew England Journal of Medicine, 1977